NFKB1 and breast carcinoma: While our focus was on breast cancer, LURAP1L-AS1 has previously been implicated in the LURAP1L/IKK/IκB/NF-κB signaling pathway in other cancers, such as oral squamous cell carcinoma (OSCC) [19].